LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

AI-Based Method Could Replace Chemical Staining of Histopathological Tissue Samples

By LabMedica International staff writers
Posted on 17 Apr 2023
Image: An example of virtual staining of tissue (Photo courtesy of University of Turku)
Image: An example of virtual staining of tissue (Photo courtesy of University of Turku)

For over a century, chemical staining has been a foundational technique in the study of histopathology, particularly in areas like cancer diagnostics. One major drawback of chemical staining, however, is its irreversible nature, which often restricts the sample's use in other tests or experiments. To address this limitation, researchers have developed an artificial intelligence (AI)-based approach to virtually stain histopathological tissue samples, potentially replacing the need for chemical staining.

A study led by researchers from the University of Eastern Finland (Kuopio, Finland) has resulted in the development of an AI method that generates computational images closely resembling those obtained through actual chemical staining. These virtually stained images can then be examined for tissue morphology. The virtual staining technique not only reduces the chemical load and manual labor required for sample processing but also allows the tissue to be used for other purposes beyond staining. A key advantage of the proposed method is that it only requires a standard light microscope and an appropriate computer, with no need for specialized hardware or infrastructure.

The rapid advancement of deep neural networks, which learn from vast amounts of data, has revolutionized biomedical image analysis. These methods are not only suitable for traditional image analysis tasks, such as interpretation, but also excel in image-to-image transformations. Virtual staining exemplifies this type of task and was effectively demonstrated by the research team.

“The results are very widely applicable. There are plenty of topics for follow-up research, and the computational methods can still be improved. However, we can already envision several application areas where virtual staining can have a major impact in histopathology,” says Associate Professor Pekka Ruusuvuori from the University of Turku, who led the computational part of the study.

“Deep neural networks are capable of performing at a level we were not able to imagine a while ago. Artificial intelligence-based virtual staining can have a major impact towards more efficient sample processing in histopathology,” said Doctoral Researcher Umair Khan from the University of Turku who was the lead developer.

Related Links:
University of Eastern Finland 

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Hemodynamic System Monitor
OptoMonitor

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more